Clinical Trial Update: Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing gemigliptin to glimepiride on cardiac diastolic function in type 2 diabetes patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)
• Glimepiride (glimepiride)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Ejection Fraction | Phase 4 | Status: UNKNOWN